Voloridge Investment Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 194,247 shares of ALNY stock, worth $47.9 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

194,247

Previous 14,863 1206.92%

Holding current value

$47.9 Million

Previous $3.61 Million 1379.73%

% of portfolio

0.2%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $41.9 Million - $51.5 Million	179,384 Added 1206.92%	194,247 $53.4 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $2.13 Million - $3.67 Million	14,863 New	14,863 $3.61 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $6.39 Million - $7.93 Million	-37,446 Reduced 50.02%	37,412 $6.63 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $12.3 Million - $14.1 Million	-66,530 Reduced 47.05%	74,858 $14.2 Million
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $12.5 Million - $16.2 Million	-68,623 Reduced 32.68%	141,388 $28.3 Million
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $25.7 Million - $33.4 Million	138,481 Added 193.6%	210,011 $49.9 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $9.91 Million - $16.6 Million	71,530 New	71,530 $14.3 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $3.54 Million - $4.97 Million	-29,380 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $3.74 Million - $5.11 Million	29,380 New	29,380 $4.8 Million
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $2 Million - $2.62 Million	-12,506 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $2.12 Million - $2.6 Million	12,506 New	12,506 $2.36 Million
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $3.58 Million - $5.15 Million	-38,410 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $2.86 Million - $4.77 Million	38,410 New	38,410 $4.42 Million
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $6.93 Million - $8.46 Million	-78,483 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $7.59 Million - $9.72 Million	65,470 Added 503.11%	78,483 $9.35 Million
Q4 2017 Feb 14, 2018	SELL	$114.49 - $139.98 $12.5 Million - $15.3 Million	-109,244 Reduced 89.36%	13,013 $1.65 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $8.87 Million - $14.5 Million	122,257	122,257 $14.4 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History